8793 related articles for article (PubMed ID: 1722659)
1. Improved treatment of disseminated B16f10 melanoma in mice with anticancer drugs in combination with L-histidinol.
Warrington RC; Fang WD
Anticancer Res; 1991; 11(5):1869-74. PubMed ID: 1722659
[TBL] [Abstract][Full Text] [Related]
2. Different effects of L-histidinol and homoharringtonine on 5-fluorouracil and bis-chloroethylnitrosourea activity in a murine model.
Warrington RC; Fang WD
Anticancer Res; 1991; 11(5):1879-83. PubMed ID: 1768059
[TBL] [Abstract][Full Text] [Related]
3. Effects of L-histidinol on the proliferation and anticancer drug susceptibility of cultured B16f10 melanoma cells.
Warrington RC; Cheng I; Fang W
Anticancer Res; 1991; 11(5):1863-7. PubMed ID: 1768057
[TBL] [Abstract][Full Text] [Related]
4. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
Warrington RC; Muzyka TG; Fang WD
Cancer Res; 1984 Jul; 44(7):2929-35. PubMed ID: 6722819
[TBL] [Abstract][Full Text] [Related]
5. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
Warrington RC; Fang WD
J Natl Cancer Inst; 1985 May; 74(5):1071-7. PubMed ID: 3858576
[TBL] [Abstract][Full Text] [Related]
6. Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice.
Warrington RC; Cheng I; Fang WD
J Natl Cancer Inst; 1987 Jun; 78(6):1177-83. PubMed ID: 3108563
[TBL] [Abstract][Full Text] [Related]
7. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice.
Zaharko D; Plowman J; Waud W; Dykes D; Malspeis L
Cancer Res; 1992 Jul; 52(13):3604-9. PubMed ID: 1617631
[TBL] [Abstract][Full Text] [Related]
8. A novel approach for improving the efficacy of experimental cancer chemotherapy using combinations of anticancer drugs and L-histidinol.
Warrington RC
Anticancer Res; 1986; 6(3 Pt B):451-64. PubMed ID: 3090929
[TBL] [Abstract][Full Text] [Related]
9. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
[TBL] [Abstract][Full Text] [Related]
10. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
[TBL] [Abstract][Full Text] [Related]
11. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ.
Lala PK; Parhar RS
Cancer Res; 1988 Mar; 48(5):1072-9. PubMed ID: 3124954
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
13. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
Shiraga E; Barichello JM; Ishida T; Kiwada H
Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
[TBL] [Abstract][Full Text] [Related]
14. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Ninomiya K; Sekido S; Araki T
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lung and liver tumor colonies in mice pretreated with suramin.
Sola F; Farao M; Marsiglio A; Mariani M; Grandi M
Invasion Metastasis; 1993; 13(3):163-8. PubMed ID: 8112976
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
17. Specificity, schedule, and proliferation dependence of infused L-histidinol after 5-fluorouracil in mice.
Edelstein MB; Heilbrun LK
Cancer Res; 1988 Mar; 48(6):1470-5. PubMed ID: 3345520
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of combinations of interferons and cytotoxic drugs in murine tumor models in vivo.
Harrison SD; Stevens JJ; Waud WR; Dykes DJ; Schmid SM; Griswold DP
J Biol Response Mod; 1990 Aug; 9(4):395-400. PubMed ID: 2118561
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
[TBL] [Abstract][Full Text] [Related]
20. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
